IDiyas

For the Inventor, By the Inventor

Hanover, Germany

Wolfgang Kehrbach

USPTO Granted Patents = 16

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • Hannover, DE (1991 - 1996)
  • Hanover, DE (1983 - 1998)

Company Filing History:

goldMedal15 out of 92 
 
Kali-chemie Pharma Gmbh
 patents
silverMedal1 out of 75 
 
Solvay Pharmaceuticals, Gmbh
 patents

Years Active: 1983-1998

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5843948 - Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, (1998-12-01),
2. 5679699 - (Phenylalkylaminoalkyloxy) -heteroaryl-compounds, processes and (1997-10-21),
3. 5547967 - (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and (1996-08-20),
4. 4983611 - 3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane intermediates and (1991-01-08),
5. 4912113 - 3,7-diazabicyclo(3,3,1)nonane compounds and pharmaceutical compositions (1990-03-27),
6. 4906640 - 3-sulfonyl-3,7-diazabicyclo[3,3,1]nonane compounds and medicaments (1990-03-06),
7. 4879299 - Treatment of heart conditions with spartein compounds (1989-11-07),
8. 4771044 - Tetraoxo compounds and pharmaceutical compositions (1988-09-13),
9. 4755520 - Spartein compounds, their preparation and use (1988-07-05),
10. 4742172 - Intermediates for synthesizing pharmaceutically active (1988-05-03),
11. 4695566 - 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, antiarrythmic (1987-09-22),
12. 4558052 - 10-Bromosandwicine, 10-bromoisosandwicine, pharmaceutical compositions (1985-12-10),
13. 4554274 - N.sub.b Quaternary derivatives of ajmaline and isoajmaline, methods and (1985-11-19),
14. 4552877 - N.sub.b -Quaternary derivatives of sandwicine and isosandwicine methods (1985-11-12),
15. 4550112 - 3,7-Diazabicyclo(3,3,1)nonane compounds and their use in treating heart (1985-10-29),

Title: Wolfgang Kehrbach: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang Kehrbach, a prominent inventor based in Hanover, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a prolific portfolio of 16 patents, his work primarily involves innovative compounds that have applications in medical treatments.

Latest Patents

Among his latest inventions are piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives. These compounds exhibit fibrinogen receptor-antagonistic activity and are represented by a specific general formula. Additionally, Kehrbach has developed phenylalkylaminoalkyloxy-heteroaryl compounds that demonstrate heart rate lowering and anti-ischemic effects. The methods for their preparation and the pharmaceutical compositions containing them are also detailed in his patents, which specify the general formulas involved.

Career Highlights

Throughout his career, Wolfgang Kehrbach has been associated with renowned companies, such as Kali-Chemie Pharma GmbH and Solvay Pharmaceuticals GmbH. His expertise and innovative mindset have allowed him to push the boundaries of chemical research, leading to significant advancements in pharmaceutical applications.

Collaborations

Kehrbach has collaborated with notable coworkers, including Gerd Buschmann and Uwe Schoen. These partnerships have played a crucial role in the success of his inventions and have fostered a rich collaborative environment that enhances the development of new therapies.

Conclusion

Wolfgang Kehrbach epitomizes the spirit of innovation in pharmaceutical science. His dedication to creating novel compounds has not only enriched his portfolio but has also contributed to the advancement of medical treatments, positioning him as a key figure in the industry. His ongoing work and collaborations promise to further impact the future of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…